Private Equity

Updated:

Zhongqi Capital

Zhongqi Capital is a joint venture between Qidi Kefu and Sinochem's subsidiary. It focuses on fund investments in new materials, new energy, biotechnology, and...

Zhongqi Capital logo

Zhongqi Capital

Zhongqi Capital is a joint venture between Qidi Kefu and Sinochem's subsidiary. It focuses on fund investments in new materials, new energy, biotechnology, and other sectors. The firm has made 17 investments, including a Series E investment in New Radiomedicine on April 03, 2026.

General information

Firm type

Private Equity

Year founded

2020

Location

Region

Asia

Country

China

City

Beijing

Corporate office

Beijing, China

Frequently asked questions

What investment stages does Zhongqi Capital typically target?

Per the firm's own classification of its strategy, Zhongqi targets early-stage venture — including seed and start-up rounds — as well as growth and late-stage expansion deals. This full-spectrum approach is characteristic of Chinese PE firms that combine venture capital and growth equity under a single mandate.

Which sectors does Zhongqi Capital explicitly avoid?

The firm has not publicly disclosed sector exclusions or negative screens. Without visibility into the portfolio, sector concentrations, or investment committee commentary, there is no basis to identify sectors the firm avoids. In the Chinese regulatory environment, sectors subject to heightened state scrutiny — such as for-profit education and certain consumer internet verticals — have become de facto no-go zones for many domestic PE firms.

What is Zhongqi Capital's known posture on co-investments alongside external GPs?

The firm has not publicly articulated a co-investment policy. No instances of Zhongqi participating in club deals, syndicated rounds alongside named external GPs, or co-investment platforms have been documented in public records. The firm's low disclosure profile makes it impossible to verify whether co-investment activity exists.

Profile maintained by using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.

Need institutional-grade insight on private equity firms?

Altss delivers:

Principals with verified direct contactsAllocation history by asset classOSINT-derived deal signals
Book a demo

Prefer a guided tour?

We’ll walk you through:

Interactive funding timelinesCustom mandate & allocation filters
Book a demo

Browse by category

More Beijing Private Equity profiles